A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 96,903 shares of LLY stock, worth $77.1 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
96,903
Previous 107,998 10.27%
Holding current value
$77.1 Million
Previous $97.8 Million 12.2%
% of portfolio
0.86%
Previous 1.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $8.57 Million - $10.7 Million
-11,095 Reduced 10.27%
96,903 $85.9 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $5.82 Million - $7.3 Million
8,030 Added 8.03%
107,998 $97.8 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $7.91 Million - $10.6 Million
-13,359 Reduced 11.79%
99,968 $77.8 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $6.09 Million - $7.18 Million
-11,603 Reduced 9.29%
113,327 $66.1 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $924,606 - $1.27 Million
2,127 Added 1.73%
124,930 $67.1 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $1.05 Million - $1.4 Million
2,986 Added 2.49%
122,803 $57.6 Million
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $642,382 - $754,447
-2,068 Reduced 1.7%
119,817 $41.1 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $2.4 Million - $2.8 Million
-7,470 Reduced 5.77%
121,885 $44.6 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $602,150 - $686,213
-2,031 Reduced 1.55%
129,355 $41.8 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $573,626 - $673,521
-2,058 Reduced 1.54%
131,386 $42.6 Million
Q1 2022

May 10, 2022

BUY
$234.69 - $291.66 $1.08 Million - $1.34 Million
4,591 Added 3.56%
133,444 $38.2 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $29 Million - $36 Million
128,853 New
128,853 $35.7 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.